Addiction Disorders Drugs Market - Global Forecast 2026-2032

The Addiction Disorders Drugs Market is witnessing structural transformation as evolving treatment paradigms, payer requirements, and regulatory changes reshape the landscape for commercial enterprises and healthcare providers alike.

Market Snapshot: Addiction Disorders Drugs Market Growth and Outlook

The global Addiction Disorders Drugs Market is experiencing significant expansion, with the market projected to grow from USD 28.89 billion in 2025 to USD 30.67 billion in 2026, and to reach USD 45.34 billion by 2032. This reflects a compound annual growth rate (CAGR) of 6.65%. Key drivers include sustained investment in pharmacotherapy innovations, increasing application of technology-enabled care, and evolving clinical guidelines. These forces together are spurring the adoption of advanced treatments and optimizing patient engagement across both established and rapidly developing regions.

Scope & Segmentation: Key Market Dimensions

Product Types: The market encompasses both branded and generic drugs, each requiring tailored lifecycle management, pricing strategies, and formulary positioning for maximum market penetration.
Dosage Forms: Capsule, film, injectable solution, patch, and tablet formats address distinct drug delivery challenges and enhance patient compliance based on demographic and treatment variables.
Administration Routes: Oral, injectable, sublingual, and transdermal options enable alignment with varied clinical protocols and once-daily, long-acting, or as-needed regimens.
Drug Classes: Alcohol, nicotine, and opioid therapeutic classes, further segmented by active agents such as acamprosate, disulfiram, naltrexone, bupropion, varenicline, buprenorphine, and methadone. The distinction between branded and generic versions is vital for procurement and reimbursement analysis.
Distribution Channels: Hospital pharmacy, online pharmacy, and retail pharmacy distribution offer differentiated access and unique dispensing controls based on therapy complexity and regulatory requirements.
End Users: Hospitals, clinics, and homecare settings each have distinct monitoring, compliance support, and ancillary service considerations that shape product adoption.
Regional Coverage: The Americas; Europe, Middle East & Africa; and Asia-Pacific regions each bring specific regulatory frameworks, reimbursement environments, and care delivery models, impacting commercial strategies and patient access.

Key Takeaways for Decision-Makers

Market developments favor integrated models of addiction treatment that combine pharmacological solutions with behavioral and digital interventions for improved patient outcomes.
Diversified product portfolios spanning branded and generic segments enable firms to align with a range of payer and provider procurement practices.
Emerging value-based reimbursement models are prompting pharmaceutical suppliers to demonstrate not only efficacy but also sustained patient outcomes and cost-effectiveness.
Long-acting injectables and novel drug delivery mechanisms are addressing longstanding adherence barriers, offering new therapeutic options especially for complex or comorbid populations.
Collaboration with digital health and telemedicine platforms is enhancing continuity of care, streamlining patient monitoring, and deepening stakeholder engagement across the care continuum.
Operational agility remains critical as evolving trade policies and supply chain disruptions influence sourcing and manufacturing strategies, requiring contingency planning and risk management.

Tariff Impact and Supply Chain Strategies

Recent tariff actions and import controls, particularly impacting the United States market, introduce heightened commercial complexity for companies reliant on international supply chains. Firms are evaluating nearshoring and supplier diversification as measures to mitigate cost exposure and secure seamless therapy availability for critical products. Flexible manufacturing capacities and vertical integration offer competitive advantages in cost management. Conversely, smaller or less integrated suppliers may face margin pressures and challenges in maintaining supply for complex formulations. Proactive scenario planning allows companies to respond effectively to evolving tariff environments and maintain access across distribution channels.

Methodology & Data Sources

This analysis draws on in-depth interviews with clinicians, payers, hospital pharmacists, specialty distributors, and regulatory authorities. Secondary sources include peer-reviewed publications, regulatory documents, market trade data, and current policy updates. Qualitative insights are triangulated with quantitative findings, ensuring rigorous and transparent methodologies underpin the conclusions presented.

Why This Report Matters

Delivers actionable insights for strategic planning, enabling senior leaders to navigate clinical, regulatory, and commercial complexities unique to addiction disorder therapeutics.
Provides segmentation analysis that empowers executive teams to tailor investment, innovation, and market access strategies in alignment with stakeholder priorities.
Equips organizations to anticipate and manage regulatory or supply chain shifts through comprehensive assessments relevant for long-term business resilience.

Conclusion

The Addiction Disorders Drugs Market is defined by ongoing innovation, evolving regulations, and new care delivery models. Businesses that prioritize clinical alignment, supply resilience, and sustained partnerships will remain well-positioned in a changing environment.

Additional Product Information:

Purchase of this report includes 1 year online access with quarterly updates.
This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025

8. Addiction Disorders Drugs Market, by Product Type

8.1. Branded
8.2. Generic

9. Addiction Disorders Drugs Market, by Dosage Form

9.1. Capsule
9.2. Film
9.3. Injectable Solution
9.4. Patch
9.5. Tablet

10. Addiction Disorders Drugs Market, by Administration Route

10.1. Injectable
10.2. Oral
10.3. Sublingual
10.4. Transdermal

11. Addiction Disorders Drugs Market, by Drug Class

11.1. Alcohol
11.1.1. Acamprosate
11.1.2. Disulfiram
11.1.3. Naltrexone
11.2. Nicotine
11.2.1. Varenicline
11.3. Opioid
11.3.1. Buprenorphine
11.3.2. Methadone
11.3.3. Naltrexone

12. Addiction Disorders Drugs Market, by Distribution Channel

12.1. Hospital Pharmacy
12.2. Online Pharmacy
12.3. Retail Pharmacy

13. Addiction Disorders Drugs Market, by End User

13.1. Clinics
13.2. Homecare Settings
13.3. Hospitals

14. Addiction Disorders Drugs Market, by Region

14.1. Americas
14.1.1. North America
14.1.2. Latin America
14.2. Europe, Middle East & Africa
14.2.1. Europe
14.2.2. Middle East
14.2.3. Africa
14.3. Asia-Pacific

15. Addiction Disorders Drugs Market, by Group

15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO

16. Addiction Disorders Drugs Market, by Country

16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea

17. United States Addiction Disorders Drugs Market
18. China Addiction Disorders Drugs Market

19. Competitive Landscape

19.1. Market Concentration Analysis, 2025
19.1.1. Concentration Ratio (CR)
19.1.2. Herfindahl Hirschman Index (HHI)
19.2. Recent Developments & Impact Analysis, 2025
19.3. Product Portfolio Analysis, 2025
19.4. Benchmarking Analysis, 2025
19.5. Accord Healthcare Limited
19.6. Alkermes plc
19.7. Aurobindo Pharma Limited
19.8. Bausch Health Companies Inc
19.9. BioDelivery Sciences International Inc
19.10. Camurus AB
19.11. Cipla Limited
19.12. GlaxoSmithKline PLC
19.13. Hikma Pharmaceuticals PLC
19.14. Indivior PLC
19.15. Insys Therapeutics Inc
19.16. Johnson & Johnson
19.17. Mallinckrodt Pharmaceuticals PLC
19.18. Orexo AB
19.19. Pfizer Inc
19.20. Purdue Pharma L.P.
19.21. Reckitt Benckiser Pharmaceuticals Inc
19.22. Teva Pharmaceutical Industries Ltd
19.23. Titan Pharmaceuticals Inc
19.24. Viatris Inc

List of Figures

FIGURE 1. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL ADDICTION DISORDERS DRUGS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL ADDICTION DISORDERS DRUGS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY DOSAGE FORM, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG CLASS, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. UNITED STATES ADDICTION DISORDERS DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 14. CHINA ADDICTION DISORDERS DRUGS MARKET SIZE, 2018-2032 (USD MILLION)

List of Tables

TABLE 1. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY BRANDED, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY BRANDED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY BRANDED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY GENERIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY GENERIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY GENERIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY CAPSULE, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY CAPSULE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY CAPSULE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY FILM, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY FILM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY FILM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY INJECTABLE SOLUTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY INJECTABLE SOLUTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY INJECTABLE SOLUTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY PATCH, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY PATCH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY PATCH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY TABLET, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY TABLET, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY TABLET, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY INJECTABLE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY INJECTABLE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY ORAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY ORAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY ORAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY SUBLINGUAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY SUBLINGUAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY SUBLINGUAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY TRANSDERMAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY TRANSDERMAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY TRANSDERMAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY ALCOHOL, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY ALCOHOL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY ALCOHOL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY ALCOHOL, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY ACAMPROSATE, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY ACAMPROSATE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY ACAMPROSATE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY DISULFIRAM, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY DISULFIRAM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY DISULFIRAM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY NALTREXONE, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY NALTREXONE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY NALTREXONE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY NICOTINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY NICOTINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY NICOTINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY NICOTINE, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY VARENICLINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY VARENICLINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY VARENICLINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY OPIOID, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY OPIOID, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY OPIOID, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY OPIOID, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY BUPRENORPHINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY BUPRENORPHINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY BUPRENORPHINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY METHADONE, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY METHADONE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY METHADONE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY NALTREXONE, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY NALTREXONE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY NALTREXONE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY HOMECARE SETTINGS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY HOMECARE SETTINGS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 93. AMERICAS ADDICTION DISORDERS DRUGS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 94. AMERICAS ADDICTION DISORDERS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 95. AMERICAS ADDICTION DISORDERS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 96. AMERICAS ADDICTION DISORDERS DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
TABLE 97. AMERICAS ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 98. AMERICAS ADDICTION DISORDERS DRUGS MARKET SIZE, BY ALCOHOL, 2018-2032 (USD MILLION)
TABLE 99. AMERICAS ADDICTION DISORDERS DRUGS MARKET SIZE, BY NICOTINE, 2018-2032 (USD MILLION)
TABLE 100. AMERICAS ADDICTION DISORDERS DRUGS MARKET SIZE, BY OPIOID, 2018-2032 (USD MILLION)
TABLE 101. AMERICAS ADDICTION DISORDERS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 102. AMERICAS ADDICTION DISORDERS DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 103. NORTH AMERICA ADDICTION DISORDERS DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 104. NORTH AMERICA ADDICTION DISORDERS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 105. NORTH AMERICA ADDICTION DISORDERS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 106. NORTH AMERICA ADDICTION DISORDERS DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
TABLE 107. NORTH AMERICA ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 108. NORTH AMERICA ADDICTION DISORDERS DRUGS MARKET SIZE, BY ALCOHOL, 2018-2032 (USD MILLION)
TABLE 109. NORTH AMERICA ADDICTION DISORDERS DRUGS MARKET SIZE, BY NICOTINE, 2018-2032 (USD MILLION)
TABLE 110. NORTH AMERICA ADDICTION DISORDERS DRUGS MARKET SIZE, BY OPIOID, 2018-2032 (USD MILLION)
TABLE 111. NORTH AMERICA ADDICTION DISORDERS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 112. NORTH AMERICA ADDICTION DISORDERS DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 113. LATIN AMERICA ADDICTION DISORDERS DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 114. LATIN AMERICA ADDICTION DISORDERS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 115. LATIN AMERICA ADDICTION DISORDERS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 116. LATIN AMERICA ADDICTION DISORDERS DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
TABLE 117. LATIN AMERICA ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 118. LATIN AMERICA ADDICTION DISORDERS DRUGS MARKET SIZE, BY ALCOHOL, 2018-2032 (USD MILLION)
TABLE 119. LATIN AMERICA ADDICTION DISORDERS DRUGS MARKET SIZE, BY NICOTINE, 2018-2032 (USD MILLION)
TABLE 120. LATIN AMERICA ADDICTION DISORDERS DRUGS MARKET SIZE, BY OPIOID, 2018-2032 (USD MILLION)
TABLE 121. LATIN AMERICA ADDICTION DISORDERS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 122. LATIN AMERICA ADDICTION DISORDERS DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA ADDICTION DISORDERS DRUGS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA ADDICTION DISORDERS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA ADDICTION DISORDERS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA ADDICTION DISORDERS DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA ADDICTION DISORDERS DRUGS MARKET SIZE, BY ALCOHOL, 2018-2032 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA ADDICTION DISORDERS DRUGS MARKET SIZE, BY NICOTINE, 2018-2032 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA ADDICTION DISORDERS DRUGS MARKET SIZE, BY OPIOID, 2018-2032 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA ADDICTION DISORDERS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA ADDICTION DISORDERS DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 133. EUROPE ADDICTION DISORDERS DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 134. EUROPE ADDICTION DISORDERS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 135. EUROPE ADDICTION DISORDERS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 136. EUROPE ADDICTION DISORDERS DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
TABLE 137. EUROPE ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 138. EUROPE ADDICTION DISORDERS DRUGS MARKET SIZE, BY ALCOHOL, 2018-2032 (USD MILLION)
TABLE 139. EUROPE ADDICTION DISORDERS DRUGS MARKET SIZE, BY NICOTINE, 2018-2032 (USD MILLION)
TABLE 140. EUROPE ADDICTION DISORDERS DRUGS MARKET SIZE, BY OPIOID, 2018-2032 (USD MILLION)
TABLE 141. EUROPE ADDICTION DISORDERS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 142. EUROPE ADDICTION DISORDERS DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 143. MIDDLE EAST ADDICTION DISORDERS DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 144. MIDDLE EAST ADDICTION DISORDERS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 145. MIDDLE EAST ADDICTION DISORDERS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 146. MIDDLE EAST ADDICTION DISORDERS DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
TABLE 147. MIDDLE EAST ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 148. MIDDLE EAST ADDICTION DISORDERS DRUGS MARKET SIZE, BY ALCOHOL, 2018-2032 (USD MILLION)
TABLE 149. MIDDLE EAST ADDICTION DISORDERS DRUGS MARKET SIZE, BY NICOTINE, 2018-2032 (USD MILLION)
TABLE 150. MIDDLE EAST ADDICTION DISORDERS DRUGS MARKET SIZE, BY OPIOID, 2018-2032 (USD MILLION)
TABLE 151. MIDDLE EAST ADDICTION DISORDERS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 152. MIDDLE EAST ADDICTION DISORDERS DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 153. AFRICA ADDICTION DISORDERS DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 154. AFRICA ADDICTION DISORDERS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 155. AFRICA ADDICTION DISORDERS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 156. AFRICA ADDICTION DISORDERS DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
TABLE 157. AFRICA ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 158. AFRICA ADDICTION DISORDERS DRUGS MARKET SIZE, BY ALCOHOL, 2018-2032 (USD MILLION)
TABLE 159. AFRICA ADDICTION DISORDERS DRUGS MARKET SIZE, BY NICOTINE, 2018-2032 (USD MILLION)
TABLE 160. AFRICA ADDICTION DISORDERS DRUGS MARKET SIZE, BY OPIOID, 2018-2032 (USD MILLION)
TABLE 161. AFRICA ADDICTION DISORDERS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 162. AFRICA ADDICTION DISORDERS DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 163. ASIA-PACIFIC ADDICTION DISORDERS DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 164. ASIA-PACIFIC ADDICTION DISORDERS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 165. ASIA-PACIFIC ADDICTION DISORDERS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 166. ASIA-PACIFIC ADDICTION DISORDERS DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
TABLE 167. ASIA-PACIFIC ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 168. ASIA-PACIFIC ADDICTION DISORDERS DRUGS MARKET SIZE, BY ALCOHOL, 2018-2032 (USD MILLION)
TABLE 169. ASIA-PACIFIC ADDICTION DISORDERS DRUGS MARKET SIZE, BY NICOTINE, 2018-2032 (USD MILLION)
TABLE 170. ASIA-PACIFIC ADDICTION DISORDERS DRUGS MARKET SIZE, BY OPIOID, 2018-2032 (USD MILLION)
TABLE 171. ASIA-PACIFIC ADDICTION DISORDERS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 172. ASIA-PACIFIC ADDICTION DISORDERS DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 173. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 174. ASEAN ADDICTION DISORDERS DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 175. ASEAN ADDICTION DISORDERS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 176. ASEAN ADDICTION DISORDERS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 177. ASEAN ADDICTION DISORDERS DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
TABLE 178. ASEAN ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 179. ASEAN ADDICTION DISORDERS DRUGS MARKET SIZE, BY ALCOHOL, 2018-2032 (USD MILLION)
TABLE 180. ASEAN ADDICTION DISORDERS DRUGS MARKET SIZE, BY NICOTINE, 2018-2032 (USD MILLION)
TABLE 181. ASEAN ADDICTION DISORDERS DRUGS MARKET SIZE, BY OPIOID, 2018-2032 (USD MILLION)
TABLE 182. ASEAN ADDICTION DISORDERS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 183. ASEAN ADDICTION DISORDERS DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 184. GCC ADDICTION DISORDERS DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 185. GCC ADDICTION DISORDERS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 186. GCC ADDICTION DISORDERS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 187. GCC ADDICTION DISORDERS DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
TABLE 188. GCC ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 189. GCC ADDICTION DISORDERS DRUGS MARKET SIZE, BY ALCOHOL, 2018-2032 (USD MILLION)
TABLE 190. GCC ADDICTION DISORDERS DRUGS MARKET SIZE, BY NICOTINE, 2018-2032 (USD MILLION)
TABLE 191. GCC ADDICTION DISORDERS DRUGS MARKET SIZE, BY OPIOID, 2018-2032 (USD MILLION)
TABLE 192. GCC ADDICTION DISORDERS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 193. GCC ADDICTION DISORDERS DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 194. EUROPEAN UNION ADDICTION DISORDERS DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 195. EUROPEAN UNION ADDICTION DISORDERS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 196. EUROPEAN UNION ADDICTION DISORDERS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 197. EUROPEAN UNION ADDICTION DISORDERS DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
TABLE 198. EUROPEAN UNION ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 199. EUROPEAN UNION ADDICTION DISORDERS DRUGS MARKET SIZE, BY ALCOHOL, 2018-2032 (USD MILLION)
TABLE 200. EUROPEAN UNION ADDICTION DISORDERS DRUGS MARKET SIZE, BY NICOTINE, 2018-2032 (USD MILLION)
TABLE 201. EUROPEAN UNION ADDICTION DISORDERS DRUGS MARKET SIZE, BY OPIOID, 2018-2032 (USD MILLION)
TABLE 202. EUROPEAN UNION ADDICTION DISORDERS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 203. EUROPEAN UNION ADDICTION DISORDERS DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 204. BRICS ADDICTION DISORDERS DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 205. BRICS ADDICTION DISORDERS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 206. BRICS ADDICTION DISORDERS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 207. BRICS ADDICTION DISORDERS DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
TABLE 208. BRICS ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 209. BRICS ADDICTION DISORDERS DRUGS MARKET SIZE, BY ALCOHOL, 2018-2032 (USD MILLION)
TABLE 210. BRICS ADDICTION DISORDERS DRUGS MARKET SIZE, BY NICOTINE, 2018-2032 (USD MILLION)
TABLE 211. BRICS ADDICTION DISORDERS DRUGS MARKET SIZE, BY OPIOID, 2018-2032 (USD MILLION)
TABLE 212. BRICS ADDICTION DISORDERS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 213. BRICS ADDICTION DISORDERS DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 214. G7 ADDICTION DISORDERS DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 215. G7 ADDICTION DISORDERS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 216. G7 ADDICTION DISORDERS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 217. G7 ADDICTION DISORDERS DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
TABLE 218. G7 ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 219. G7 ADDICTION DISORDERS DRUGS MARKET SIZE, BY ALCOHOL, 2018-2032 (USD MILLION)
TABLE 220. G7 ADDICTION DISORDERS DRUGS MARKET SIZE, BY NICOTINE, 2018-2032 (USD MILLION)
TABLE 221. G7 ADDICTION DISORDERS DRUGS MARKET SIZE, BY OPIOID, 2018-2032 (USD MILLION)
TABLE 222. G7 ADDICTION DISORDERS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 223. G7 ADDICTION DISORDERS DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 224. NATO ADDICTION DISORDERS DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 225. NATO ADDICTION DISORDERS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 226. NATO ADDICTION DISORDERS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 227. NATO ADDICTION DISORDERS DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
TABLE 228. NATO ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 229. NATO ADDICTION DISORDERS DRUGS MARKET SIZE, BY ALCOHOL, 2018-2032 (USD MILLION)
TABLE 230. NATO ADDICTION DISORDERS DRUGS MARKET SIZE, BY NICOTINE, 2018-2032 (USD MILLION)
TABLE 231. NATO ADDICTION DISORDERS DRUGS MARKET SIZE, BY OPIOID, 2018-2032 (USD MILLION)
TABLE 232. NATO ADDICTION DISORDERS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 233. NATO ADDICTION DISORDERS DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 234. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 235. UNITED STATES ADDICTION DISORDERS DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 236. UNITED STATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 237. UNITED STATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 238. UNITED STATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
TABLE 239. UNITED STATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 240. UNITED STATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY ALCOHOL, 2018-2032 (USD MILLION)
TABLE 241. UNITED STATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY NICOTINE, 2018-2032 (USD MILLION)
TABLE 242. UNITED STATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY OPIOID, 2018-2032 (USD MILLION)
TABLE 243. UNITED STATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 244. UNITED STATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 245. CHINA ADDICTION DISORDERS DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 246. CHINA ADDICTION DISORDERS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 247. CHINA ADDICTION DISORDERS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 248. CHINA ADDICTION DISORDERS DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
TABLE 249. CHINA ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 250. CHINA ADDICTION DISORDERS DRUGS MARKET SIZE, BY ALCOHOL, 2018-2032 (USD MILLION)
TABLE 251. CHINA ADDICTION DISORDERS DRUGS MARKET SIZE, BY NICOTINE, 2018-2032 (USD MILLION)
TABLE 252. CHINA ADDICTION DISORDERS DRUGS MARKET SIZE, BY OPIOID, 2018-2032 (USD MILLION)
TABLE 253. CHINA ADDICTION DISORDERS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 254. CHINA ADDICTION DISORDERS DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Addiction Disorders Drugs market report include:

Accord Healthcare Limited
Alkermes plc
Aurobindo Pharma Limited
Bausch Health Companies Inc
BioDelivery Sciences International Inc
Camurus AB
Cipla Limited
GlaxoSmithKline PLC
Hikma Pharmaceuticals PLC
Indivior PLC
Insys Therapeutics Inc
Johnson & Johnson
Mallinckrodt Pharmaceuticals PLC
Orexo AB
Pfizer Inc
Purdue Pharma L.P.
Reckitt Benckiser Pharmaceuticals Inc
Teva Pharmaceutical Industries Ltd
Titan Pharmaceuticals Inc
Viatris Inc

Table Information

Report Attribute	Details
No. of Pages	191
Published	January 2026
Forecast Period	2026 - 2032
Estimated Market Value ( USD ) in 2026	$ 30.67 Billion
Forecasted Market Value ( USD ) by 2032	$ 45.34 Billion
Compound Annual Growth Rate	6.6%
Regions Covered	Global
No. of Companies Mentioned	21

License	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access	This is a single user license, allowing one user access to the product.	€3504EUR$3,939USD£3,037GBP
1 - 5 USER LICENSE PDF, Excel and Online Access	This is a 1-5 user license, allowing up to five users have access to the product.	€3779EUR$4,249USD£3,276GBP
SITE LICENSE PDF, Excel and Online Access	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5123EUR$5,759USD£4,440GBP
ENTERPRISE LICENSE PDF, Excel and Online Access	This is an enterprise license, allowing all employees within your organization access to the product.	€6199EUR$6,969USD£5,372GBP

Market Snapshot: Addiction Disorders Drugs Market Growth and Outlook

Scope & Segmentation: Key Market Dimensions

Key Takeaways for Decision-Makers

Tariff Impact and Supply Chain Strategies

Methodology & Data Sources

Why This Report Matters

Conclusion

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

Disulfiram Market - Global Forecast 2026-2032

Addictions Therapeutics Market Report 2025

Naltrexone and Buprenorphine - Global Strategic Business Report

Substance Use Disorder Therapeutics Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Product Type

Alcohol Use Disorder Market - Global Forecast 2026-2032